Health care stocks were mixed premarket Tuesday, with The Health Care Select Sector SPDR Fund (XLV) marginally higher and the iShares Biotechnology ETF (IBB) down 0.6%.
Illumina (ILMN) is now prohibited from exporting gene sequencers to China as the company was added to the country's "Unreliable Entity List," according to a statement from China's Ministry of Commerce. Illumina shares were down more than 4% pre-bell.
Wave Life Sciences (WVE) stock was nearly 4% higher after the company reported that it swung to Q4 net income as revenue rose during the period.
BeiGene (ONC) shares were up over 2% after the company said the US Food and Drug Administration approved Tevimbra, in combination with platinum-containing chemotherapy, for the first-line treatment of certain adults with unresectable or metastatic esophageal squamous cell carcinoma.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.